Overview
Holly Lee practices in Toronto, Canada. Lee is rated as an Experienced expert by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Their top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Primary Amyloidosis, and Severe Acute Respiratory Syndrome (SARS).
Their clinical research consists of co-authoring 42 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Monoclonal Gammopathy of Undetermined Significance (MGUS).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Multiple MyelomaLee isAdvanced. Learn about Multiple Myeloma.
- Experienced
- GlomerulonephritisLee isExperienced. Learn about Glomerulonephritis.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Polycythemia VeraLee isExperienced. Learn about Polycythemia Vera.
- Primary AmyloidosisLee isExperienced. Learn about Primary Amyloidosis.
- Severe Acute Respiratory Syndrome (SARS)
- Waldenstrom Macroglobulinemia